Cargando…
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
BACKGROUND: Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have been recently approved for treatment of patients with metastatic melanoma and non-small cell lung cancer (NSCLC). Despite important clinical benefit...
Autores principales: | Koelzer, Viktor H., Rothschild, Sacha I., Zihler, Deborah, Wicki, Andreas, Willi, Berenika, Willi, Niels, Voegeli, Michèle, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791920/ https://www.ncbi.nlm.nih.gov/pubmed/26981243 http://dx.doi.org/10.1186/s40425-016-0117-1 |
Ejemplares similares
-
Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy
por: Koelzer, Viktor H., et al.
Publicado: (2016) -
Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors
por: Paasinen-Sohns, Aino, et al.
Publicado: (2017) -
Two distinct immunopathological profiles in autopsy lungs of COVID-19
por: Nienhold, Ronny, et al.
Publicado: (2020) -
Alpha 1-antitrypsin retention in an ectopic liver
por: Dettmer, Matthias, et al.
Publicado: (2011) -
Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome
por: Koelzer, Viktor H., et al.
Publicado: (2016)